科学研究

  • 学术会议:神经及运动系统机...
    2022-04-06
  • 学术报告:Decoding the Non...
    2021-12-24
  • 前沿讲堂:Developing TCR-ba...
    2021-10-13

会员登录

用户名:
密码:

2022年度论文动态

Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway

Jiadi Lv # 1, Yuying Liu # 1, Siqi Mo # 1, Yabo Zhou 1, Fengye Chen 1, Feiran Cheng 1, Cong Li 2, Dilizhatai Saimi 1, Mengyu Liu 1, Huafeng Zhang 3, Ke Tang 3, Jingwei Ma 3, Zhenfeng Wang 1, Qiangqiang Zhu 1, Wei-Min Tong 4, Bo Huang 5 6

 

Nat Cell Biol.2022 Mar;24(3):364-372. doi: 10.1038/s41556-022-00857-4.

PMID: 35292781

 

Abstract

Pancreatic ductal adenocarcinoma (PDAC) originates from normal pancreatic ducts where digestive juice is regularly produced. It remains unclear how PDAC can escape autodigestion by digestive enzymes. Here we show that human PDAC tumour cells use gasdermin E (GSDME), a pore-forming protein, to mediate digestive resistance. GSDME facilitates the tumour cells to express mucin 1 and mucin 13, which form a barrier to prevent chymotrypsin-mediated destruction. Inoculation of GSDME-/- PDAC cells results in subcutaneous but not orthotopic tumour formation in mice. Inhibition or knockout of mucin 1 or mucin 13 abrogates orthotopic PDAC growth in NOD-SCID mice. Mechanistically, GSDME interacts with and transports YBX1 into the nucleus where YBX1 directly promotes mucin expression. This GSDME-YBX1-mucin axis is also confirmed in patients with PDAC. These findings uncover a unique survival mechanism of PDAC cells in pancreatic microenvironments.